SCN1A and Dravet syndrome: Scn1a+/- heterozygous KO mice mimic features of DS and provide a potential screening platform to investigate novel therapeutics (Kalume et al., 2013; Miller et al., 2014; Mistry et al., 2014; Kang et al., 2019).